Aarhus University Seal

Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Xue Lin, Denmark
  • Jian Li, University of Copenhagen, University of Southern Denmark, Denmark
  • Guangliang Yin
  • ,
  • Qian Zhao
  • ,
  • Daniel Elias, Ditzel-gruppen, Denmark
  • Anne E Lykkesfeldt, Denmark
  • Jan Stenvang, 2012 Faggruppe Patobiologi, Denmark
  • Nils Brünner, Denmark
  • Jun Wang, Denmark
  • Huanming Yang
  • ,
  • Lars Bolund
  • Henrik J Ditzel, Denmark
Development of resistance to tamoxifen is an important clinical issue in the treatment of breast cancer. Tamoxifen resistance may be the result of acquisition of epigenetic regulation within breast cancer cells, such as DNA methylation, resulting in changed mRNA expression of genes pivotal for estrogen-dependent growth. Alternatively, tamoxifen resistance may be due to selection of pre-existing resistant cells, or a combination of the two mechanisms.
Original languageEnglish
JournalBreast Cancer Research (Online Edition)
Pages (from-to)R119
Publication statusPublished - 19 Dec 2013

See relations at Aarhus University Citationformats

ID: 67992254